Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Zevalin (Ibritumomab Tiuxetan) Injection
Company:  IDEC Pharmaceuticals Corporation
Application No.:  125019
Approval Date: 2/19/2002


Date created: December 082005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.